1. Home
  2. ALV vs CYTK Comparison

ALV vs CYTK Comparison

Compare ALV & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Autoliv Inc.

ALV

Autoliv Inc.

HOLD

Current Price

$121.13

Market Cap

9.0B

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$76.11

Market Cap

10.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALV
CYTK
Founded
1953
1997
Country
Sweden
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
10.7B
IPO Year
1997
2004

Fundamental Metrics

Financial Performance
Metric
ALV
CYTK
Price
$121.13
$76.11
Analyst Decision
Buy
Strong Buy
Analyst Count
12
19
Target Price
$134.00
$89.26
AVG Volume (30 Days)
729.9K
1.7M
Earning Date
04-17-2026
05-05-2026
Dividend Yield
3.07%
N/A
EPS Growth
18.78
N/A
EPS
3.24
N/A
Revenue
$10,815,000,000.00
$13,368,000.00
Revenue This Year
$2.10
$7.37
Revenue Next Year
$3.47
$310.19
P/E Ratio
$37.77
N/A
Revenue Growth
4.09
N/A
52 Week Low
$99.16
$35.22
52 Week High
$132.17
$88.31

Technical Indicators

Market Signals
Indicator
ALV
CYTK
Relative Strength Index (RSI) 49.03 42.42
Support Level $113.89 $73.95
Resistance Level $124.61 $79.66
Average True Range (ATR) 2.82 2.88
MACD -0.07 -0.47
Stochastic Oscillator 47.33 15.31

Price Performance

Historical Comparison
ALV
CYTK

About ALV Autoliv Inc.

Autoliv Inc is a developer, manufacturer, and supplier of passive safety systems to the automotive industry with a broad range of product offerings. Its product portfolio includes passive safety systems for commercial vehicles, battery cut-off switches, safety solutions for riders of motorcycles and bikes, airbags (including steering wheels and inflators), seatbelts, etc. Geographically, the group operates in the Americas, Europe, China, and Asia, excluding China, of which the maximum revenue is generated from its business in the Americas.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: